EUVIMEDEUVIMED entdecken
Crossref

Diosgenin ameliorating non‐alcoholic fatty liver disease via Nrf2 ‐mediated regulation of oxidative stress and ferroptosis

Xin Zhang, Guoliang Yin, Suwen Chen, Decheng Meng, Wenfei Yu, Hongshuai Liu, Linya Wang, Fengxia Zhang iD

Diabetes, Obesity and Metabolism · 2024-12 · 26 (12) · 5745-5756

DOI: 10.1111/dom.15945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 30.09.2024. Verfasst von Xin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Ferroptosis, Oxidative Stress, NF-E2-Related Factor 2. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to investigate the mechanisms through which diosgenin inhibits the pathogenesis of non‐alcoholic fatty liver disease, focusing particularly on ferroptosis‐related pathways and its reliance on nuclear factor erythroid 2‐related factor 2 . Materials and Methods Using a rat model, we showed diosgenin's efficacy in reducing lipid deposition throughout the body and examined its impact on ferroptosis‐related gene expression in vivo . Moreover, in vitro experiments using human hepatocellular liver carcinoma cell line cells were conducted to assess oxidative stress and ferroptosis levels.

Results

Diosgenin decreased lipid accumulation and steatosis; lowered serum levels of total cholesterol, triglycerides, low‐density lipoprotein cholesterol, glutamic pyruvic transaminase and glutamic oxaloacetic transaminase; reduced interleukin‐1β and tumour necrosis factor‐α; diosgenin decreased malondialdehyde levels; and increased serum superoxide dismutase levels in a rat model of high‐fat diet‐induced non‐alcoholic fatty liver disease. Diosgenin upregulated the expression of nuclear factor erythroid 2‐related factor 2 and its downstream ferroptosis‐related genes to inhibit ferroptosis in the livers of rats with non‐alcoholic fatty liver disease. Diosgenin decreased reactive oxygen species levels and enhanced the expression of ferroptosis‐related genes in human hepatocellular liver carcinoma cells induced by free fatty acids, with its effects being dependent on nuclear factor erythroid 2‐related factor 2 .

Conclusions

This study highlights the potential of diosgenin from Dioscoreaceae plants in mitigating oxidative stress and ferroptosis levels through nuclear factor erythroid 2‐related factor 2 regulation, offering novel insights into the treatment of non‐alcoholic fatty liver disease and other metabolic disorders through traditional Chinese medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseFerroptosisOxidative StressNF-E2-Related Factor 2DiosgeninAnimalsRatsMaleHumansRats, Sprague-DawleyDiet, High-FatLiverLipid MetabolismDisease Models, Animal

Stichwörter der Autor:innen

fatty liver diseaselipid‐lowering therapylivermouse modelpharmacodynamics

Substanzen

NF-E2-Related Factor 2DiosgeninNfe2l2 protein, rat

Autor:innen und Institutionen

  • Department of The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

ORCID-Profile: Fengxia Zhang

Zitieren

APA

Zhang, X., Yin, G., Chen, S., Meng, D., Yu, W., Liu, H., Wang, L., & Zhang, F. (2024). Diosgenin ameliorating non‐alcoholic fatty liver disease via Nrf2 ‐mediated regulation of oxidative stress and ferroptosis. Diabetes, Obesity and Metabolism, 26(12), 5745-5756. https://doi.org/10.1111/dom.15945

Vancouver

Zhang X, Yin G, Chen S, Meng D, Yu W, Liu H, et al. Diosgenin ameliorating non‐alcoholic fatty liver disease via Nrf2 ‐mediated regulation of oxidative stress and ferroptosis. Diabetes, Obesity and Metabolism. 2024;26(12):5745-5756. doi:10.1111/dom.15945

BibTeX
@article{Zhang2024,
  author = {Zhang, Xin and Yin, Guoliang and Chen, Suwen and Meng, Decheng and Yu, Wenfei and Liu, Hongshuai and Wang, Linya and Zhang, Fengxia},
  title = {Diosgenin ameliorating non‐alcoholic fatty liver disease via Nrf2 ‐mediated regulation of oxidative stress and ferroptosis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {12},
  pages = {5745--5756},
  doi = {10.1111/dom.15945}
}
Kostenlos starten →